JP2019527714A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019527714A5 JP2019527714A5 JP2019507125A JP2019507125A JP2019527714A5 JP 2019527714 A5 JP2019527714 A5 JP 2019527714A5 JP 2019507125 A JP2019507125 A JP 2019507125A JP 2019507125 A JP2019507125 A JP 2019507125A JP 2019527714 A5 JP2019527714 A5 JP 2019527714A5
- Authority
- JP
- Japan
- Prior art keywords
- chain fatty
- fatty acids
- individual
- short
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2016903143A AU2016903143A0 (en) | 2016-08-10 | Metabolites for treatment of autoimmune disease | |
| AU2016903143 | 2016-08-10 | ||
| PCT/AU2017/050845 WO2018027274A1 (en) | 2016-08-10 | 2017-08-10 | Metabolites for treatment and prevention of autoimmune disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019527714A JP2019527714A (ja) | 2019-10-03 |
| JP2019527714A5 true JP2019527714A5 (https=) | 2020-10-22 |
| JP7097027B2 JP7097027B2 (ja) | 2022-07-07 |
Family
ID=61160999
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019507125A Active JP7097027B2 (ja) | 2016-08-10 | 2017-08-10 | 自己免疫疾患の処置及び予防のための代謝物 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20190167615A1 (https=) |
| EP (1) | EP3496708B1 (https=) |
| JP (1) | JP7097027B2 (https=) |
| CN (1) | CN109562088A (https=) |
| AU (1) | AU2017310263B2 (https=) |
| CA (1) | CA3070939A1 (https=) |
| ES (1) | ES3029611T3 (https=) |
| WO (1) | WO2018027274A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11065217B2 (en) * | 2017-01-27 | 2021-07-20 | Temple University—Of the Commonwealth System of Higher Education | Use of short chain fatty acids for the treatment and prevention of diseases and disorders |
| WO2020073087A1 (en) * | 2018-10-09 | 2020-04-16 | Monash University | Combination therapy for treatment and prevention of autoimmune and inflammatory diseases |
| CN109771404A (zh) * | 2019-02-28 | 2019-05-21 | 北京大学人民医院(北京大学第二临床医学院) | 丁酸在制备预防和/或治疗自身免疫性疾病药物中的应用 |
| EP3838283A1 (en) * | 2019-12-18 | 2021-06-23 | Mundus Sanus GmbH & Co. KG | Composition for use in the treatment of provocative diseases |
| AU2021283005A1 (en) * | 2020-06-03 | 2022-12-08 | Corn Products Development, Inc. | Compositions of tri-substituted starch and methods for making and using the same |
| JP2022092605A (ja) * | 2020-12-10 | 2022-06-22 | 森下仁丹株式会社 | 経口固形製剤および経口組成物 |
| CN115068458B (zh) * | 2022-07-21 | 2023-12-12 | 哈尔滨医科大学 | 戊酸在制备防治糖尿病药物中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5039703A (en) * | 1989-11-16 | 1991-08-13 | Breuer Richard I | Method for treating inflammatory bowel disorders |
| US5840860A (en) * | 1993-11-17 | 1998-11-24 | Commonwealth Scientific And Industrial Research Organization | Fatty acid delivery system comprising a hydrolyzable bond |
| AUPQ132599A0 (en) | 1999-07-01 | 1999-07-22 | Commonwealth Scientific And Industrial Research Organisation | Nasogastric enteral formulations |
| DE102005046237A1 (de) | 2005-09-28 | 2007-04-05 | Südzucker Aktiengesellschaft Mannheim/Ochsenfurt | Buttersäureester von Kohlenhydraten und Kohlenhydratpolyolen |
| US9693977B2 (en) * | 2013-03-15 | 2017-07-04 | President And Fellows Of Harvard College | Method of increasing the quantity of colonic T regulatory cells via G-coupled protein receptor 43 |
| EP3063271A4 (en) * | 2013-10-31 | 2017-05-03 | Sloan-Kettering Institute for Cancer Research | Methods and compositions for inducing regulatory t-cell generation |
| US10226443B2 (en) * | 2014-10-16 | 2019-03-12 | New York University | Methods for treating psoriatic arthritis |
| MA41020A (fr) | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
| US11065217B2 (en) * | 2017-01-27 | 2021-07-20 | Temple University—Of the Commonwealth System of Higher Education | Use of short chain fatty acids for the treatment and prevention of diseases and disorders |
| WO2020073087A1 (en) * | 2018-10-09 | 2020-04-16 | Monash University | Combination therapy for treatment and prevention of autoimmune and inflammatory diseases |
-
2017
- 2017-08-10 CN CN201780049297.2A patent/CN109562088A/zh active Pending
- 2017-08-10 WO PCT/AU2017/050845 patent/WO2018027274A1/en not_active Ceased
- 2017-08-10 AU AU2017310263A patent/AU2017310263B2/en active Active
- 2017-08-10 US US16/323,726 patent/US20190167615A1/en not_active Abandoned
- 2017-08-10 ES ES17838221T patent/ES3029611T3/es active Active
- 2017-08-10 JP JP2019507125A patent/JP7097027B2/ja active Active
- 2017-08-10 EP EP17838221.4A patent/EP3496708B1/en active Active
- 2017-08-10 CA CA3070939A patent/CA3070939A1/en active Pending
-
2021
- 2021-02-17 US US17/178,211 patent/US20210244692A1/en not_active Abandoned
-
2025
- 2025-04-10 US US19/175,560 patent/US20250295617A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019527714A5 (https=) | ||
| Hua et al. | Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue | |
| CN114641293A (zh) | 一种fgfr抑制剂的用途 | |
| JP2016520590A (ja) | 治療薬および使用法 | |
| JP7053478B2 (ja) | Ｆｘｒアゴニストを使用するための方法 | |
| CN103458893B (zh) | Sn‑1(3)单酰基甘油酯和脂质吸收 | |
| RU2016127232A (ru) | Антисмысловые композиции и способы их получения и применения | |
| CA2570184A1 (en) | Pharmaceutical compositions containing polyunsaturated fatty acid and at least one of an immunosuppressive agent or an antineoplastic agent | |
| JP6389889B2 (ja) | 炎症性腸疾患の治療用の医薬製剤におけるアンドログラホリドの適用、アンドログラホリド腸溶性標的マイクロペレット及びその作製方法 | |
| BRPI0812729A2 (pt) | materiais e métodos para tratamento e diagnósticos de distúrbios associados com estresse oxidativo | |
| JP2015038135A5 (https=) | ||
| JP2017512194A5 (https=) | ||
| JP2016530279A5 (https=) | ||
| Kandula et al. | Discovery and preclinical development of a novel prodrug conjugate of mesalamine with eicosapentaenoic acid and caprylic acid for the treatment of inflammatory bowel diseases | |
| JP2017519028A5 (https=) | ||
| JP2015504438A5 (https=) | ||
| Avogaro et al. | Incretins and the cardiovascular system: bridging digestion with metabolism | |
| HRP20220999T1 (hr) | Terapija za ulcerozni kolitis zasnovana na oligonukleotidu | |
| CN102058571A (zh) | 4-[(5,6,7,8-四氢-5,5,8,8-四甲基-2-萘基)氨基甲酰基]苯甲酸在制备用于预防及/或治疗肠粘连的药物中的应用 | |
| CN112315934A (zh) | 白头翁皂苷b4肠溶片的制备工艺 | |
| BRPI0622007A2 (pt) | uso de aminossalicilato para tratar colite ulcerativa | |
| Li et al. | Gut microbiota-derived metabolites as novel therapies for inflammatory bowel diseases: Role of nuclear receptors | |
| ES2980614T3 (es) | Composición farmacéutica que contiene lisozima y uso de la misma | |
| CN104983728B (zh) | 金合欢素在制备防治溃疡性结肠炎的药物或食品中的应用 | |
| CN105079012B (zh) | 天麻素在制备防治溃疡性结肠炎的药物或食品中的应用 |